ZBIO — Zenas Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Zenas Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K
Standards:	USG	USG	USG
Status:	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	67.2	56.9	351
Prepaid Expenses
Total Other Current Assets
Total Current Assets	68.4	59.8	356
Net Property, Plant And Equipment	1.8	1.01	1.19
Other Long Term Assets
Total Assets	74.6	68.2	370
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	26	23.3	57.3
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	26.8	43.8	57.5
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	47.8	24.4	312
Total Liabilities & Shareholders' Equity	74.6	68.2	370
Total Common Shares Outstanding